Skip to main content
  • Twitter
  • GitHub
  • search

Main navigation

  • What We Do
  • Updates
  • HAC Blog
  • Partners
  • Team
  • What is...?

Updates

Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid Cancers

JAMA Oncology |
2021

Automated Text-Based Symptom Monitoring With Rapid Clinician Triage for Patients With Cancer and Suspected or Confirmed COVID-19

JCO Clinical Cancer Informatics |
2021

Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial

BMJ Open |
2021

Quality of life in cancer care

Med |
2021

Identification and characterization of key long non-coding RNAs in the mouse cochlea

RNA Biol |
2021

I’m an oncologist who treats prostate cancer. For many patients and their manhood, the cure seems worse than the disease.

Washington Post |
2020

Understanding One Challenge in Cutting Health Care Costs

Harvard Business Review |
2020

A nudge helps doctors bring up end-of-life issues with their dying cancer patients

STAT |
2020

First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis

Future Oncology |
2020

Integrating machine-generated mortality estimates and behavioral nudges to promote serious illness conversations for cancer patients: Design and methods for a stepped-wedge cluster randomized controlled trial

Contemporary Clinical Trials |
2020

Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer

JAMA Oncology |
2020

Evaluating the Impact of Oncology Care Model Reporting Requirements on Biomarker Testing and Treatment

JCO Oncology Practice |
2020

Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of Life

JCO Oncology Practice |
2020

Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer

JAMA Oncology |
2020

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018

JAMA Network Open |
2020

Effect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer: A Stepped-Wedge Cluster Randomized Clinical Trial

JAMA Oncology |
2020

New Cancer Therapies Offer Great Hope, but There Can be Surprising Complications.

Washington Post |
2019

Metastasis-Free Survival in Prostate Cancer: Faster Drug Approvals, Better Drugs?

Journal of Clinical Oncology |
2019

Regulation of predictive analytics in medicine

Science |
2019

Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World Practice

The Oncologist |
2019

Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology

ASCO Educational Book |
2019

Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer

JAMA Network Open |
2019

Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer

European Urology |
2019

Characteristics of Physicians Participating in Medicare’s Oncology Care Model Bundled Payment Program

JCO Oncology Practice |
2019

Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

JAMA |
2019

Machine Learning Approaches to Predict 6-Month Mortality Among Patients With Cancer

JAMA Network Open |
2019

Addressing Bias in Artificial Intelligence in Health Care

JAMA |
2019

New Mexico Cancer Center and the COME HOME Model: Pathways improving the value of community-based cancer care

Healthcare |
2018

Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy

JAMA Network Open |
2018

High content screen for identifying small-molecule LC3B-localization modulators in a renal cancer cell line

Sci Data |
2018

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Next page ››
  • Last page Last »

Research Categories

  • Trustworthy AI for Healthcare
  • Clinical Evaluation of AI Decision Support
  • AI Policy
  • Next-Generation Clinical Trials
  • Big Data in Oncology

Sign up for HACLAB updates

Contact us

Human Algorithm
Collaboration Lab

Email
haclab@emory.edu


data-height="300"
data-width="100%"
href="https://twitter.com/HACLab_">
Tweets by HACLab_

© 2025 Emory University
Emory University